EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Primary Care–Based Digital Health–Enabled Stroke Management Intervention

Primärversorgungsbasierte digital unterstützte Intervention zum Schlaganfallmanagement

Jie Tan, Enying Gong, John A Gallis, Shifeng Sun, Xingxing Chen, Elizabeth L Turner, Siran Luo, Jingying Duan, Zixiao Li, Yilong Wang, Bolu Yang, Shiyu Lu und 9 weitere

JAMA Network Open · 13.12.2024 · 7 (12) · e2449561

DOI: 10.1001/jamanetworkopen.2024.49561 ↗

Auf einen Blick

In einer Cluster-RCT in China war die 1-jährige SINEMA-Intervention 5,5 Jahre später mit niedrigerem systolischem Blutdruck und weniger Schlaganfallrezidiven verbunden.

Fragestellung

Verbessert das systemintegrierte, technologiegestützte Modell SINEMA langfristig systolischen Blutdruck und andere Outcomes bei Schlaganfallpatient:innen?

Methode

Offene Cluster-randomisierte klinische Studie mit langfristigem Post-Trial-Follow-up; 50 Dörfer randomisiert, Intervention 1 Jahr, Nachbeobachtung 5,5 Jahre nach Baseline.

Ergebnisse

Bei 998 ausgewerteten Schlaganfallüberlebenden betrug die Nettoveränderung des systolischen Blutdrucks −2,8 mm Hg (95 %-KI −5,3 bis −0,3; P = .03). Schlaganfallrezidive: absolute Netto-Reduktion 6,0 Prozentpunkte; RR 0,77 (95 %-KI 0,61–0,99).

Schlussfolgerung der Autor:innen

Die 1-jährige Intervention war mit signifikant geringerem systolischem Blutdruck und weniger Schlaganfallrezidiven nach 5,5 Jahren verbunden und zeigte langfristige sowie ungleichheitsreduzierende Effekte.

Kernaussagen

  • Systolischer Blutdruck: Netto −2,8 mm Hg nach 5,5 Jahren
  • Schlaganfallrezidive: absolute Netto-Reduktion 6,0 Prozentpunkte
  • Die Effekte zeigten sich auch in Subgruppen mit niedrigerem Bildungs- und Einkommensniveau

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 13.12.2024. Verfasst von Jie Tan und 20 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Stroke, Primary Health Care, Telemedicine. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Despite evidence of the short-term benefits of multicomponent primary care–based interventions, their long-term effects are unproven.

Objective

To evaluate the long-term outcomes of a system-integrated technology-enabled model of care (SINEMA intervention) for stroke management for systolic blood pressure (BP) and other outcomes among patients with stroke in China. Design, Setting, and Participants This long-term follow-up included community-dwelling clinically stable surviving participants with stroke in an open-label cluster randomized clinical trial. Of 218 villages from Nanhe County in Hebei, China, an area with suboptimal health care resources and stroke prevalence doubling the national average, 50 villages (clusters) were recruited between June 23 and July 29, 2017, and randomized in a 1:1 ratio to an intervention or a control arm (usual care). The intervention lasted 1 year (to July 31, 2018), with a posttrial observational follow-up conducted from October 1, 2022, to August 27, 2023.

Interventions

Village doctors were provided with training, performance-based incentives, technical support, and customized mobile health tools to deliver monthly follow-up to patients. Patients also received daily voice messages emphasizing medication adherence and physical activity. No intervention was requested or supported during the posttrial period. Main Outcomes and Measures Between-arm differences in intention-to-treat analyses of individual-level changes from baseline to long-term posttrial in systolic BP (primary outcome) and stroke recurrence, diastolic BP, BP control, antihypertensive medication use and regimen adherence, and disability (secondary outcomes).

Results

Among a total of 1042 stroke survivors, 44 (4.2%) were lost to follow-up and 998 (mean [SD] age at baseline: 65.0 [8.2] years; 544 [54.4%] men) completed posttrial assessment at a mean (SD) period of 66.6 (3.7) months (5.5 years) after baseline. The multicomponent intervention was associated with an estimated between-arm net reduction in systolic BP of −2.8 (95% CI, −5.3 to −0.3) mm Hg ( P = .03). Most secondary outcomes showed a tendency toward lasting effects, with a notable absolute net reduction of 6.0 (95% CI, −11.3 to −0.7) percentage points and risk ratio of 0.77 (95% CI, 0.61-0.99) for stroke recurrence. In subgroup analyses, significant between-arm differences were observed among women and people with lower educational attainment, lower income, and higher use of and adherence to medications. Conclusions and Relevance In this long-term follow-up of a cluster randomized clinical trial, the 1-year intervention was associated with significantly reduced systolic BP and stroke recurrence at 5.5 years, providing evidence of long-term health and inequity-reducing benefits and holding promise for scaling up of the intervention in resource-limited settings. Trial Registration ClinicalTrials.gov Identifier: NCT05792618

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokePrimary Health CareTelemedicineHumansMaleFemaleMiddle AgedAgedFollow-Up StudiesChinaBlood PressureDigital Health

Autor:innen und Institutionen

  • School of Public Health, Wuhan University, Wuhan, China.
  • Global Health Research Center, Duke Kunshan University, Kunshan, China.
  • School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Duke Global Health Institute, Duke University, Durham, North Carolina.
  • Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.

Förderung

  • Medical Research Council

Zitieren

APA

Tan, J., Gong, E., Gallis, J. A., Sun, S., Chen, X., Turner, E. L., Luo, S., Duan, J., Li, Z., Wang, Y., Yang, B., Lu, S., Tang, S., Bettger, J. P., Oldenburg, B., Miranda, J. J., Karmacharya, B., Kinra, S., Shao, R., …, & Yan, L. L. (2024). Primary Care–Based Digital Health–Enabled Stroke Management Intervention. JAMA Network Open, 7(12), e2449561. https://doi.org/10.1001/jamanetworkopen.2024.49561

Vancouver

Tan J, Gong E, Gallis JA, Sun S, Chen X, Turner EL, et al. Primary Care–Based Digital Health–Enabled Stroke Management Intervention. JAMA Network Open. 2024;7(12):e2449561. doi:10.1001/jamanetworkopen.2024.49561

BibTeX
@article{Tan2024,
  author = {Tan, Jie and Gong, Enying and Gallis, John A and Sun, Shifeng and Chen, Xingxing and Turner, Elizabeth L and Luo, Siran and Duan, Jingying and Li, Zixiao and Wang, Yilong and Yang, Bolu and Lu, Shiyu and Tang, Shenglan and Bettger, Janet P and Oldenburg, Brian and Miranda, J Jaime and Karmacharya, Biraj and Kinra, Sanjay and Shao, Ruitai and Ebrahim, Shah and Yan, Lijing L},
  title = {Primary Care–Based Digital Health–Enabled Stroke Management Intervention},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {12},
  pages = {e2449561},
  doi = {10.1001/jamanetworkopen.2024.49561}
}
Kostenlos starten →